Literature DB >> 11330403

Postprandial blood glucose latency after oatmeal is a valid screening test for diabetic gastropathy in type 1 diabetes, but not in type 2 diabetes.

B Jüngling1, T Schleiffer, A Buttmann, K Kraatz, S Kress, M Vogt, J Windeler, J F Riemann.   

Abstract

Disordered gastric motility occurs frequently in diabetes mellitus. Gastric emptying time is abnormal in about 50% of diabetic patients and delayed emptying time is known as an important cause for brittle diabetes in type 1 diabetes. We compared the rise in blood glucose after a standardized meal (oatmeal test) as a noninvasive screening test for diabetic gastropathy with the noninvasive measurement of gastric emptying time with ultrasound in type 1 and type 2 diabetic patients. The test result was considered pathological if the rise of blood glucose after an initial steady state did not reach 20 mg/dl in the first 20 min after the meal (prolonged blood glucose latency). We found a sensitivity of 90% (58.7-99.8) and a specificity of 100% (71.5-100) for the oatmeal test in type 1 diabetes in the gastropathy screening. In type 2 diabetes we found a sensitivity of 13% (1.5-38.3) and a specificity of 78% (60-90.7) (95% CI). In conclusion, the oatmeal test seemed to be a good, noninvasive screening test in diabetic gastropathy in type 1 diabetes, but has no diagnostic value in type 2 diabetes. The causes for such a difference may be due to a different postprandial blood glucose regulation in type 2 diabetes compared to the beta-cell-depleted type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11330403     DOI: 10.1023/a:1010727712346

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  45 in total

1.  Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus.

Authors:  E Schvarcz; M Palmér; J Aman; M Horowitz; M Stridsberg; C Berne
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

Review 2.  Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment.

Authors:  M Horowitz; M Edelbroek; R Fraser; A Maddox; J Wishart
Journal:  Scand J Gastroenterol       Date:  1991-07       Impact factor: 2.423

3.  Prevalence and determinants of solid and liquid gastric emptying in unstable type I diabetes. Relationship to postprandial blood glucose concentrations.

Authors:  E B Lyrenås; E H Olsson; U C Arvidsson; T J Orn; J H Spjuth
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

4.  Gastric emptying delay and gastric electrical derangement in IDDM.

Authors:  S Cucchiara; A Franzese; G Salvia; L Alfonsi; V D Iula; A Montisci; F L Moreira
Journal:  Diabetes Care       Date:  1998-03       Impact factor: 19.112

5.  Reduced gastric emptying and mesenteric blood flow in IDDM with cardiac autonomic neuropathy.

Authors:  M Weck; P Ott; K Matthies
Journal:  Acta Med Austriaca       Date:  1997

6.  Measurement of gastric emptying time by real-time ultrasonography.

Authors:  L Bolondi; M Bortolotti; V Santi; T Calletti; S Gaiani; G Labò
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

7.  Autonomic neuropathy in diabetes mellitus: a follow-up study.

Authors:  G Sundkvist; B Lilja
Journal:  Diabetes Care       Date:  1985 Mar-Apr       Impact factor: 19.112

8.  Gastric myoelectrical activity in patients with type I diabetes mellitus and autonomic neuropathy.

Authors:  H J Jebbink; P P Bruijs; B Bravenboer; L M Akkermans; G P vanBerge-Henegouwen; A J Smout
Journal:  Dig Dis Sci       Date:  1994-11       Impact factor: 3.199

Review 9.  Disorders of gastrointestinal motility associated with diabetes mellitus.

Authors:  M Feldman; L R Schiller
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

Review 10.  Epidemiology of gastrointestinal complications of diabetes mellitus.

Authors:  G R Locke
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-08       Impact factor: 2.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.